Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Recent blog posts
Latest Hotspot
8 min read
CFHR2 Biologics Sequence Review Report 2026: Complement factor H-related protein 2 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CFHR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CFHR1 Biologics Sequence Review Report 2026: Complement factor H-related protein 1 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CFHR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CEACAM8 Biologics Sequence Review Report 2026: Cell adhesion molecule CEACAM8 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CEACAM8 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CENPB Biologics Sequence Review Report 2026: Major centromere autoantigen B Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CENPB protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CEACAM3 Biologics Sequence Review Report 2026: Cell adhesion molecule CEACAM3 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CEACAM3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CEACAM21 Biologics Sequence Review Report 2026: Cell adhesion molecule CEACAM21 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CEACAM21 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CEACAM7 Biologics Sequence Review Report 2026: Cell adhesion molecule CEACAM7 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CEACAM7 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CEACAM4 Biologics Sequence Review Report 2026: Cell adhesion molecule CEACAM4 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CEACAM4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CEACAM19 Biologics Sequence Review Report 2026: Cell adhesion molecule CEACAM19 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CEACAM19 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CEACAM20 Biologics Sequence Review Report 2026: Cell adhesion molecule CEACAM20 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CEACAM20 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CEACAM16 Biologics Sequence Review Report 2026: Cell adhesion molecule CEACAM16 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CEACAM16 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CEACAM18 Biologics Sequence Review Report 2026: Cell adhesion molecule CEACAM18 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CEACAM18 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
2
3
4
5
>>
1036
>